119 related articles for article (PubMed ID: 9620669)
1. Construction and expression of a soluble form of human CD30 ligand with functional activity.
Powell IF; Li T; Jäck HM; Ellis TM
J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies.
Franke AC; Jung D; Ellis TM
Hybridoma; 2000 Feb; 19(1):43-8. PubMed ID: 10768840
[TBL] [Abstract][Full Text] [Related]
3. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
5. In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30(+)T cells.
Tinazzi E; Barbieri A; Rigo A; Patuzzo G; Beri R; Gerli R; Argentino G; Puccetti A; Lunardi C
Immunol Lett; 2014 Oct; 161(2):236-40. PubMed ID: 24447865
[TBL] [Abstract][Full Text] [Related]
6. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
[TBL] [Abstract][Full Text] [Related]
7. CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
[TBL] [Abstract][Full Text] [Related]
8. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.
Hargreaves PG; Al-Shamkhani A
Eur J Immunol; 2002 Jan; 32(1):163-73. PubMed ID: 11754357
[TBL] [Abstract][Full Text] [Related]
10. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.
Jung W; Krueger S; Renner C; Gause A; Sahin U; Trümper L; Pfreundschuh M
Mol Immunol; 1994 Dec; 31(17):1329-34. PubMed ID: 7527901
[TBL] [Abstract][Full Text] [Related]
12. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
Hsu PL; Hsu SM
Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
[TBL] [Abstract][Full Text] [Related]
13. Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling.
Nakashima M; Watanabe M; Uchimaru K; Horie R
Biol Cell; 2018 May; 110(5):109-124. PubMed ID: 29431186
[TBL] [Abstract][Full Text] [Related]
14. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
16. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
17. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.
Kim MY; Anderson G; White A; Jenkinson E; Arlt W; Martensson IL; Erlandsson L; Lane PJ
J Immunol; 2005 Jun; 174(11):6686-91. PubMed ID: 15905508
[TBL] [Abstract][Full Text] [Related]
18. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line.
Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Improta S; Juzbasic S; Todesco M; Perin V; Gattei V; Herrmann F; Gruss HJ; Carbone A
Blood; 1996 Nov; 88(9):3299-305. PubMed ID: 8896393
[TBL] [Abstract][Full Text] [Related]
19. CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease.
Somada S; Muta H; Nakamura K; Sun X; Honda K; Ihara E; Akiho H; Takayanagi R; Yoshikai Y; Podack ER; Tani K
Dig Dis Sci; 2012 Aug; 57(8):2031-7. PubMed ID: 22451116
[TBL] [Abstract][Full Text] [Related]
20. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
